Results 171 to 180 of about 114,360,625 (248)

Nipple-Originating Solid Papillary Carcinoma In Situ: A Case Report and Literature Review. [PDF]

Clin Case Rep
Yang Y, Hao X, Zhai Y, Xie X, Ma X.
europepmc   +1 more source

Refining OVCAR‐3 xenograft models of peritoneal carcinomatosis in nu/nu mice: Comparative intraperitoneal implantation strategies and the role of basement membrane matrix

Animal Models and Experimental Medicine, EarlyView.
A refined murine model of advanced ovarian cancer was established by comparing localized preperitoneal implantation and intraperitoneal injection of OVCAR‐3Luc cells. While localized implantation showed limited tumor persistence, intraperitoneal delivery with BME produced sustained diffuse dissemination confirmed by BLI and histology, providing a ...
M. Teresa Perelló‐Trias, Antonio Jose Serrano‐Muñoz, Juan J. Segura‐Sampedro, Adriana M. Quintero‐Duarte, Joana M. Ramis, Marta Monjo   +5 more
wiley   +1 more source

Radiotherapy for Ductal Carcinoma In Situ: Toxicity, Quality of Life, and Decisional Regret at a Tertiary Cancer Center. [PDF]

Cancers (Basel)
Alhasan HA, Schirmer MA, Dröge LH, Zwerenz CM, Guhlich M, Donath S, Rieken S, Felmerer G, Bendrich S.   +8 more
europepmc   +1 more source

Activation of Metal Complexes With Ultrasound Waves for Targeted Anticancer Therapy

Angewandte Chemie International Edition, EarlyView.
Ultrasound enables non‐invasive activation of metal‐based therapeutics deep within tumors. Acoustic cavitation can drive sonodynamic reactive oxygen species generation or mechanochemical metal–ligand bond dissociation, enabling controlled release of bioactive payloads.
Félix Grosjean, Nicolás Montesdeoca, Gilles Berger, Johannes Karges   +3 more
wiley   +1 more source

Msh2,Mlh1,Fhit, p53,Bcl2 and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix.

, 2000
ALDERISIO M, FHIT, P, BAX EXPRESSION IN INVASIVE AND IN SITU SQUAMOUS CELL CARCINOMA OF THE UTERINE CERVIX, VECCHIONE, Aldo, PISANI T, GIARNIERI, Enrico, BCL, MSH, MLH, MANCINI, RITA, CLIN CANCER R.E.S. SEP   +9 more
core  

The Malignant Transformation Rate of Oral Carcinoma In Situ. [PDF]

Laryngoscope
Meci A, Goyal N, Goldenberg D.
europepmc   +1 more source

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

British Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher, Amina Džidić‐Krivić, Emma Pinjic, Nejra Selak, Kanita Omerbasic, Alexandar Chupin, Andrej Belancic, Almir Fajkic   +7 more
wiley   +1 more source

Development and Validation of an Algorithm to Achieve Complete Registration of Danish Patients with Carcinoma In Situ of the Breast, 2008-2023. [PDF]

Clin Epidemiol
Simonsen MK, Grantzau TL, Jensen MB, Cronin-Fenton D, Offersen BV, Tramm T.   +5 more
europepmc   +1 more source

Risk factors for ductal carcinoma in situ: comparisons with invasive breast cancer. [PDF]

Breast Cancer Res
Abe JV, Fukui J, Wilkens LR, Cheng I, Wu AH, Hernandez BY, Loo LWM.   +6 more
europepmc   +1 more source

Integrated spherical nucleic acid nanoreactor mobilizes targeted PD‐L1 proteolysis and cuproptosis for robust breast cancer immunotherapy

BMEMat, EarlyView.
This study provides an integrated spherical nucleic acid nanoreactor (denoted as AMCuD) for targeted PD‐L1 degradation and chemo‐dynamically enhanced cuproptosis to synergically elicit robust immunotherapy against the triple‐negative breast cancer (TNBC) growth, recurrence and metastasis.
Ningxi Li, Honglin Huang, Qianyi Zeng, Li Zeng, Ziman Yang, Jinyang Shen, Shun Li, Hong Yang, Yiyao Liu, Chunhui Wu   +9 more
wiley   +1 more source